Oryzon Genomics Eulerpool vesti

Oryzon Genomics Eulerpool News

Oryzon Genomics Akcija Vesti

Oryzon Genomics праћен је од стране многих новинара и инвеститора широм света. Најсвежије Oryzon Genomics вести окупљамо овде.

• 31. јул ·

  Yahoo
  ORYZON reports financial results and corporate update for half-year ending June 30, 2024
• 8. јул ·

  Yahoo
  ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
• 28. јун ·

  Yahoo
  ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
• 26. јун ·

  Yahoo
  ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
• 14. јун ·

  Yahoo
  ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
• 3. јун ·

  Yahoo
  ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
• 30. мај ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in June
• 29. мај ·

  Yahoo
  ORYZON Selected as Associated Partner in the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)
• 9. мај ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in May
• 6. мај ·

  Yahoo
  ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024